Table 1.
Effect of GAlbudAb on post-ischemic left ventricle hemodynamic
| Parameter | Vehicle | GAlbudAb (2 mg/kg) |
|---|---|---|
| N |
8 |
9 |
| LVSP (mmHg) |
107 ± 3.0 |
112 ± 2.6 |
| LVEDP (mmHg) |
12.8 ± 1.0 |
8.6 ± 1.5* |
| HR (bpm) |
425 ± 5 |
419 ± 10 |
| dP/dtmax (mmHg/s) |
6628 ± 273 |
7612 ± 219* |
| dP/dtmin (mmHg/s) | 5682 ± 311 | 6746 ± 341* |
N, number of animals; LVSP, left ventricle systolic pressure; LVEDP, left ventricle end diastolic pressure; HR, heart rate; dP/dtmax, maximum rates of change in the left ventricle pressure; dP/dtmin, minimum rates of change in left ventricle pressure. Data are presented as mean ± SEM. *p < 0.05 vs. vehicle.